Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
ASCO 2014 – Lung Cancer
Gefitinib Plus Carboplatin/Pemetrexed as First-Line Therapy of EGFR+ NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
Read Article
First-Line Nivolumab Monotherapy in Advanced NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Results from the ARCHER 1009 Study: Dacomitinib Versus Erlotinib for Second-/Third-Line Therapy of Locally Advanced or Metastatic NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Results from PROFILE 1014: First-Line Crizotinib Versus Pemetrexed-Platinum in ALK+ NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Erlotinib Plus Bevacizumab as First-Line Treatment for EGFR+, Advanced NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
Read Article
A Mutant-Selective EGFR Inhibitor in NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Ceritinib in Advanced ALK-Rearranged NSCLC: Results from the ASCEND-1 Trial
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Docetaxel and Cisplatin Plus Chemoradiation in Inoperable Stage III NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Results from RADIANT: Adjuvant Erlotinib in NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Breaking News from the REVEL Study in NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Page 1 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Addressing Cancer Health Disparities: The No One Left Alone Initiative
Rohan Nathwani
,
Arva Patel
,
Warner Kornberg
,
Asutosh Gor, MD
,
Sashi Naidu, MD
,
Viral Rabara, MD
,
Niyati Nathwani, MD
,
Kashyap Patel, MD
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
Talvey Receives Accelerated Approval for Relapsed or Refractory Multiple Myeloma
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma